Establishment Labs Holdings Inc (FRA:3E0)
€ 43.2 0 (0%) Market Cap: 1.20 Bil Enterprise Value: 1.34 Bil PE Ratio: 0 PB Ratio: 41.09 GF Score: 78/100

Establishment Labs Holdings Inc at UBS Global Healthcare Conference Transcript

May 20, 2019 / 05:30PM GMT
Release Date Price: €22.28 (-2.15%)
Jonathan Waksman
UBS Group AG - Investment Banking Associate Director

Great. So I think we'll just about ready to get started. Welcome all to the 2019 UBS Global Healthcare Conference. My name is Jonathan Waksman. I'll be your host for this session. It's my pleasure to introduce Juan Jose Chacon, founder and CEO of Establishment Labs. And as a reminder, Q&A will be held downstairs in the breakout session. I think the room is Alvin-Carnegie. Thanks.

Juan Jose Chacon Quiros
Establishment Labs Holdings Inc. - Founder, CEO & Executive Director

Okay. So thank you for being here. As Jonathan said, I am Juan Jose Chacon Quiros. You can call me JJ as well. I'm founder and CEO of Establishment Labs. And our company is dedicated to women's health initially in the breast aesthetics and reconstruction area.

So what we've been doing over last few years is really bringing to market a differentiated product portfolio that is known for its advanced aesthetics. We really have been able to create a technology that focuses on women's needs. And on top of that,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot